EE9400255A - Kolmikasendatud pürimido[5,4-d]pürimidiinid multimedikamentse resistentsuse mõjutajana, neid ühendeid sisaldavad ravimid ning nende saamise meetodid - Google Patents

Kolmikasendatud pürimido[5,4-d]pürimidiinid multimedikamentse resistentsuse mõjutajana, neid ühendeid sisaldavad ravimid ning nende saamise meetodid

Info

Publication number
EE9400255A
EE9400255A EE9400255A EE9400255A EE9400255A EE 9400255 A EE9400255 A EE 9400255A EE 9400255 A EE9400255 A EE 9400255A EE 9400255 A EE9400255 A EE 9400255A EE 9400255 A EE9400255 A EE 9400255A
Authority
EE
Estonia
Prior art keywords
pyrimidines
agents
compounds
preparation
methods
Prior art date
Application number
EE9400255A
Other languages
English (en)
Estonian (et)
Inventor
Heckel Armin
Bamberger Uwe
Mauz Annerose
Original Assignee
Dr. Karl Thomae Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Karl Thomae Gmbh filed Critical Dr. Karl Thomae Gmbh
Publication of EE9400255A publication Critical patent/EE9400255A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EE9400255A 1993-08-02 1994-11-23 Kolmikasendatud pürimido[5,4-d]pürimidiinid multimedikamentse resistentsuse mõjutajana, neid ühendeid sisaldavad ravimid ning nende saamise meetodid EE9400255A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4325900A DE4325900A1 (de) 1993-08-02 1993-08-02 Trisubstituierte Pyrimido [5,4-d] pyrimidine zur Modulation der Multidrugresistenz, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
EE9400255A true EE9400255A (et) 1996-02-15

Family

ID=6494272

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400255A EE9400255A (et) 1993-08-02 1994-11-23 Kolmikasendatud pürimido[5,4-d]pürimidiinid multimedikamentse resistentsuse mõjutajana, neid ühendeid sisaldavad ravimid ning nende saamise meetodid

Country Status (22)

Country Link
US (1) US5618814A (fr)
EP (1) EP0645390A1 (fr)
JP (1) JPH0789963A (fr)
KR (1) KR950005828A (fr)
CN (1) CN1041091C (fr)
AU (1) AU683888B2 (fr)
BG (1) BG98931A (fr)
CA (1) CA2129179A1 (fr)
CZ (1) CZ184594A3 (fr)
DE (1) DE4325900A1 (fr)
EE (1) EE9400255A (fr)
FI (1) FI943574A (fr)
HU (1) HUT70957A (fr)
IL (1) IL110509A (fr)
NO (1) NO301479B1 (fr)
NZ (1) NZ264133A (fr)
PL (1) PL304512A1 (fr)
RO (1) RO113557B1 (fr)
RU (1) RU94028278A (fr)
SK (1) SK91594A3 (fr)
TW (1) TW251286B (fr)
ZA (1) ZA945689B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW414798B (en) * 1994-09-07 2000-12-11 Thomae Gmbh Dr K Pyrimido (5,4-d) pyrimidines, medicaments comprising these compounds, their use and processes for their preparation
DE19608653A1 (de) * 1996-03-06 1997-09-11 Thomae Gmbh Dr K Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
USRE37234E1 (en) * 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US7618975B2 (en) * 2003-07-03 2009-11-17 Myriad Pharmaceuticals, Inc. 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2592900A1 (fr) 2005-01-03 2006-07-13 Myriad Genetics Inc. Composes et utilisation therapeutique associee
CN115650827B (zh) * 2022-10-27 2024-03-15 戊言医药科技(上海)有限公司 用于一类蒽环类毒素衍生物的制备方法、中间体化合物及合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3069211D1 (en) * 1979-07-03 1984-10-25 Thomae Gmbh Dr K 2-(perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them
DE2931573A1 (de) * 1979-08-03 1981-02-26 Thomae Gmbh Dr K Mittel zur bekaempfung des wachstums von krebszellen und dessen herstellung
DE3049207A1 (de) * 1980-12-27 1982-07-29 Dr. Karl Thomae Gmbh, 7950 Biberach Neue trisubstituierte pyrimido (5,4-d) pyrimidine, ihre herstellung und ihre verwendung als arzneimittel
DE3423092A1 (de) * 1984-06-22 1986-01-02 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 8-alkylthio-2-piperazino-pyrimido(5,4-d) pyrimidine, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3833392A1 (de) * 1988-10-01 1990-04-05 Thomae Gmbh Dr K Verwendung von pyrimido(5,4-d)pyrimidinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
KR950005828A (ko) 1995-03-20
NO942853D0 (fr) 1994-08-01
FI943574A0 (fi) 1994-08-01
NZ264133A (en) 1996-05-28
AU6881394A (en) 1995-02-09
CA2129179A1 (fr) 1995-02-03
FI943574A (fi) 1995-02-03
NO942853L (no) 1995-02-03
RO113557B1 (ro) 1998-08-28
SK91594A3 (en) 1995-04-12
IL110509A0 (en) 1994-10-21
IL110509A (en) 1998-01-04
AU683888B2 (en) 1997-11-27
NO301479B1 (no) 1997-11-03
ZA945689B (en) 1996-02-01
DE4325900A1 (de) 1995-02-09
PL304512A1 (en) 1995-02-06
US5618814A (en) 1997-04-08
EP0645390A1 (fr) 1995-03-29
TW251286B (fr) 1995-07-11
HU9402253D0 (en) 1994-09-28
RU94028278A (ru) 1996-08-27
CZ184594A3 (en) 1995-02-15
CN1106405A (zh) 1995-08-09
BG98931A (en) 1995-09-29
HUT70957A (en) 1995-11-28
JPH0789963A (ja) 1995-04-04
CN1041091C (zh) 1998-12-09

Similar Documents

Publication Publication Date Title
EE9800278A (et) Pürimido[5,4-d]pürimidiinid, neid ühendeid sisaldavad ravimid, nende kasutamine ja valmistamismeetodid
EE04193B1 (et) Triasolo[4,5-d]pürimidiini ühendid, neid sisaldavad ravimkoostised ja nende valmistamise meetodid
EE9800289A (et) Pürimido[5,4-d]pürimidiinid, neid ühendeid sisaldavad ravimid, nende kasutamine ja valmistamismeetodid
HUP9801336A3 (en) 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and pharmaceutical compositions containing them
HUP0100202A3 (en) Novel triazolo[4,5-d]pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
EE9600019A (et) 2,8-diasendatud kinasolinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
HUP9801587A3 (en) 5h-thiazolo[3,2-a]pyrimidine derivatives, process for their preparation, intermediates, use of the compounds and pharmaceutical compositions containing them
IL105092A0 (en) Optionally substituted pyrido(2,3-d)pyrimidine-2,4-(1h,3h)-diones and pyrido(2,3-d)pyrimidine-2(1h,3h)-ones,their preparation and pharmaceutical compositions containing them
PL337695A1 (en) 4-halogenoalkyl-3-heterocyclylpyridines and 4-halogenoalkyl-3-heterocyclyl pyrimidines, methods of obtaining them, agents containing such compounds and their application as pesticides
IL116775A (en) Tricyclic azolobenzodiazepines and similar compounds their preparation and pharmaceutical compositions containing them
EE9400255A (et) Kolmikasendatud pürimido[5,4-d]pürimidiinid multimedikamentse resistentsuse mõjutajana, neid ühendeid sisaldavad ravimid ning nende saamise meetodid
PL322452A1 (en) 6-arylpyrasole [3,4-d]pyrimidin-4-ones, preparations containing such compounds and methods of mking use of them
FI934182A (fi) Foerfarande foer framstaellning av 5-substituerade pyrrolo(2,3-d)pyrimidiner
IS4350A (is) Trísýklísk 5,6-díhýdró-9H-pýrazóló[3,4c]-1,2,4-tríazóló[4,3a]pýridín, notkun þeirra og lyfjablanda
DE68925270D1 (de) Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidinderivate und diese enthaltende Arzneimittel
HUP9900611A3 (en) 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives, pharmaceutical compositions containing them and intermediates for the preparation of the compounds
AP9801275A0 (en) Use of tricyclic 1,4-dihydro-1,4-dioxo-1H-naphthalene derivatives resulting novel compounds and therapeutical use thereof
PT935598E (pt) Derivados de 3-oxo-pirido (1,2-a)benzimidazole-4-carboxamida alquilo substituidos contendo 5 heteroatomos uteis no tratamento de disturbios do sistema nervoso central
HUP0203579A3 (en) Pyrazolo[1,5-d][1,2,4]triazines for enhancing cognition and pharmaceutical compositions containing them and their use
PL340381A1 (en) Novel 19-norsteroids substituted at position 11beta, method of obtaining them, intermediate compounds used in that method, their application as drugs and pharmacological compositions containing them
ZA957464B (en) Pyrimido[5,4-d]pyrimidines medicaments comprising these compounds their use and processes for the preparation
DK0820455T3 (da) 5H,10H-Imidazo[1,2-e]indeno[1,2-e]pyrazin-4-on-derivater, fremstilling af disse forbindelser og lægemidler indeholdende disse forbindelser
ZA955942B (en) 4-hydroxy-3-phenylindeno[1,2-b]pyridin-2(1H)-one derivatives their preparation and the medicaments containing them
FI933872A (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4H)-on-derivat
IL151811A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CRF RECEPTOR ANTAGONIST 3-ARYL-5, 7-DISUBSTITUTED PYRAZOLO [1,5-a]- PYRIMIDINE DERIVATIVES, SEVERAL SUCH NEW COMPOUNDS AND THEIR PREPARATION